ACE Inhibitors: Drug List, Side Effects, Mechanism of Action, Example Medications, Contraindications — EZmed
![Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy - The Lancet Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy - The Lancet](https://www.thelancet.com/cms/attachment/ebe44c06-df88-460d-8bd0-bcaf0d30f149/gr1.gif)
Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy - The Lancet
![Recommendations for the treatment of confirmed hypertension in people... | Download Scientific Diagram Recommendations for the treatment of confirmed hypertension in people... | Download Scientific Diagram](https://www.researchgate.net/publication/328613278/figure/fig1/AS:704058528632832@1544872042232/Recommendations-for-the-treatment-of-confirmed-hypertension-in-people-with-diabetes-An.jpg)
Recommendations for the treatment of confirmed hypertension in people... | Download Scientific Diagram
![Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study) Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study)](https://www.bmj.com/content/bmj/328/7438/495/F1.large.jpg)
Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study)
![ACE Inhibitor Use and Major Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus Taking a DPP-4 Inhibitor - American College of Cardiology ACE Inhibitor Use and Major Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus Taking a DPP-4 Inhibitor - American College of Cardiology](https://www.acc.org/-/media/Non-Clinical/Images/Latest-in-Cardiology/Articles/2017/02/2017Feb09_WhiteDiabetes_Fig1B.png?la=en&hash=23309784DEF72F9FEC282670B18B31C11608209C)
ACE Inhibitor Use and Major Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus Taking a DPP-4 Inhibitor - American College of Cardiology
![ACE inhibitors and ARBs: Managing potassium and renal function | Cleveland Clinic Journal of Medicine ACE inhibitors and ARBs: Managing potassium and renal function | Cleveland Clinic Journal of Medicine](https://www.ccjm.org/content/ccjom/86/9/601/F1.large.jpg)
ACE inhibitors and ARBs: Managing potassium and renal function | Cleveland Clinic Journal of Medicine
![Mechanisms by which angiotensin-converting enzyme inhibitors prevent diabetes and cardiovascular disease - ScienceDirect Mechanisms by which angiotensin-converting enzyme inhibitors prevent diabetes and cardiovascular disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0002914903004326-gr1.jpg)
Mechanisms by which angiotensin-converting enzyme inhibitors prevent diabetes and cardiovascular disease - ScienceDirect
![DPP4 (Dipeptidyl Peptidase-4) Inhibition Increases Catecholamines Without Increasing Blood Pressure During Sustained ACE (Angiotensin-Converting Enzyme) Inhibitor Treatment | Hypertension DPP4 (Dipeptidyl Peptidase-4) Inhibition Increases Catecholamines Without Increasing Blood Pressure During Sustained ACE (Angiotensin-Converting Enzyme) Inhibitor Treatment | Hypertension](https://www.ahajournals.org/cms/asset/3123b137-2a02-44ab-955b-d0a466d7a621/hypertensionaha.121.18348.fig04.jpg)
DPP4 (Dipeptidyl Peptidase-4) Inhibition Increases Catecholamines Without Increasing Blood Pressure During Sustained ACE (Angiotensin-Converting Enzyme) Inhibitor Treatment | Hypertension
![Addition of cyclic angiotensin-(1-7) to angiotensin-converting enzyme inhibitor therapy has a positive add-on effect in experimental diabetic nephropathy - ScienceDirect Addition of cyclic angiotensin-(1-7) to angiotensin-converting enzyme inhibitor therapy has a positive add-on effect in experimental diabetic nephropathy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0085253819304867-fx1.jpg)
Addition of cyclic angiotensin-(1-7) to angiotensin-converting enzyme inhibitor therapy has a positive add-on effect in experimental diabetic nephropathy - ScienceDirect
![Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy - The Lancet Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy - The Lancet](https://www.thelancet.com/cms/attachment/2002726525/2009697562/gr1.gif)